Beyond the PSA: The hidden costs of screening in prostate cancer

被引：0
|
作者：
Sanyal, Chiranjeev [1 ]
Ragavan, Meera V. [2 ]
机构：
[1] Dalhousie Univ, Coll Pharm, Halifax, NS, Canada
[2] Kaiser Permanente, Div Res, Pleasanton, CA USA
来源：
CANCER | 2024年 / 130卷 / 19期
关键词：
BURDEN;
D O I：
10.1002/cncr.35474
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The diagnostic workup following a positive prostate-specific antigen test may lead to significant out-of-pocket costs for patients. Providers should incorporate costs into shared decision-making with patients; in parallel, policymakers and payers must identify solutions to mitigate financial burdens that risk widening existing disparities in prostate cancer care.
引用
收藏
页码：3272 / 3274
页数：3
相关论文
共 50 条
  • [1] Screening for Prostate Cancer—Beyond Total PSA, Utilization of Novel Biomarkers
    Todd Morgan
    Ganesh Palapattu
    John Wei
    Current Urology Reports, 2015, 16
  • [2] PSA screening for prostate cancer
    Wilt, Timothy J.
    Dahm, Philipp
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [3] PSA screening for prostate cancer
    Sadi, Marcus V.
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2017, 63 (08): : 722 - 725
  • [4] Beyond PSA testing for prostate cancer
    Brooks, Doug
    Olver, Ian N.
    Esterman, Adrian J.
    MEDICAL JOURNAL OF AUSTRALIA, 2018, 208 (10) : 424 - 426
  • [5] Moving beyond negative campaign for PSA-based screening for prostate cancer
    Ito, Kazuto
    Sekine, Yoshitaka
    Suzuki, Kazuhiro
    Kurosawa, Isao
    CANCER SCIENCE, 2023, 114 : 1536 - 1536
  • [6] Improving Prostate Cancer Screening and Diagnosis Health Policy and Biomarkers Beyond PSA
    Patel, Hiten D.
    Chalfin, Heather J.
    Carter, H. Ballentine
    JAMA ONCOLOGY, 2016, 2 (07) : 867 - 868
  • [7] Screening for Prostate Cancer-Beyond Total PSA, Utilization of Novel Biomarkers
    Morgan, Todd
    Palapattu, Ganesh
    Wei, John
    CURRENT UROLOGY REPORTS, 2015, 16 (09)
  • [8] The use of PSA for screening of prostate cancer
    Stenman, Ulf-Hakan
    TUMOR BIOLOGY, 2006, 27 : 45 - 45
  • [9] PSA screening and prostate cancer mortality
    Perron, L
    Moore, L
    Bairati, I
    Bernard, PM
    Meyer, FO
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2002, 166 (05) : 586 - 591
  • [10] PSA Screening and Prostate Cancer Mortality
    Goldstein, Mark R.
    Mascitelli, Luca
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (10):
12345